• yl23455永利官网

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR2100042645】Dr. Muhammad Usman Javed: please fill in the date of approved by ethic committee. COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CO

    基本信息
    登记号

    ChiCTR2100042645

    试验状态

    结束

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2021-01-24

    临床申请受理号

    /

    靶点

    /

    适应症

    肾石症

    试验通俗题目

    Dr. Muhammad Usman Javed: please fill in the date of approved by ethic committee. COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CO

    试验专业题目

    COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CONTROLLED TRIAL.

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    60000

    联系人通讯地址
    临床试验信息
    试验目的

    To compare peri tract infiltration of Bupivacaine augmented by oral post-operative analgesia versus post-operative intravenous analgesia alone in patients undergoing percutaneous nephrolithotomy in terms of mean post-operative pain score

    试验分类
    试验类型

    随机平行对照

    试验分期

    探索性研究/预试验

    随机化

    lottery method

    盲法

    Not stated

    试验项目经费来源

    None

    试验范围

    /

    目标入组人数

    34

    实际入组人数

    /

    第一例入组时间

    2019-04-11

    试验终止时间

    2019-10-10

    是否属于一致性

    /

    入选标准

    a. All patients undergoing PCNL; b. Age from 12-65 years; c. Normal Renal Functions; d. No history of chronic pain; e. ASA I, II & III; f. Both genders.;

    排除标准

    a. History of local anesthesia allergy; b. Redo PCNL; c. Multiple punctures during PCNL; d. Excessive intra-operative bleeding; e. Diabetes Mellitus; f. Coagulopathy; g. Mental Disorder; h. ASA IV & V; i. Active urinary tract infection.;

    研究者信息
    研究负责人姓名
    试验机构

    None

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    60000

    联系人通讯地址

    None的其他临床试验

    更多

    最新临床资讯

    yl23455永利官网企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品

    同适应症药物临床试验

    更多